EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study

Aoi Noda iD, Ryutaro Arita, Taku Obara, Satoko Suzuki, Minoru Ohsawa, Ryo Obara, Kei Morishita, Fumihiko Ueno, Fumiko Matsuzaki, Genki Shinoda, Keiko Murakami, Masatsugu Orui iD und 5 weitere

Pharmacoepidemiology and Drug Safety · 2024

DOI: 10.1002/pds.70033 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Aoi Noda und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan. Hauptthemen laut MEDLINE: Medicine, Kampo. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Japanese traditional (Kampo) medicines are often used for pregnant women in Japan. However, no comprehensive studies have been conducted regarding the self‐reported use of these medicines during pregnancy. This study investigated the use of Kampo medicines during pregnancy in Japan using the Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study (TMM BirThree Cohort Study).

Methods

Questionnaires were distributed to pregnant women participating in the TMM BirThree Cohort Study (July 2013 to March 2017) at approximately 12 weeks (early pregnancy) and 26 weeks (middle pregnancy). We analysed Kampo medicines use over three periods: (1) 12 months before pregnancy diagnosis, (2) the period between pregnancy diagnosis and around Week 12 of pregnancy and (3) from around Week 12 of pregnancy.

Results

In total, 19 220 women were included in the analysis. The proportions using prescribed Kampo medicines were 4.1% before pregnancy diagnosis, 4.5% from diagnosis to Week 12% and 4.5% after Week 12 of pregnancy. The most frequently prescribed Kampo medicines were tokishakuyakusan (1.0%) before pregnancy diagnosis, shoseiryuto (1.3%) from diagnosis to Week 12 and shoseiryuto (1.5%) Post‐week 12. Sixty of the pregnant women used Kampo medicines containing crude drugs, which should be administered cautiously during pregnancy.

Conclusion

The proportion of Kampo medicines use before and during pregnancy was 4%–5%. Some pregnant women used Kampo medicines containing crude drugs that should be administered cautiously during pregnancy. Further research is required to determine the safety of Kampo medicines during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medicine, KampoHumansPregnancyFemaleJapanAdultCohort StudiesSurveys and QuestionnairesDrugs, Chinese HerbalYoung AdultEast Asian People

Stichwörter der Autor:innen

Kampo medicinebirth cohortmedication usepregnancy

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Division of Molecular Epidemiology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.
  • Department of Kampo and Integrative Medicine, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Department of Education and Support for Regional Medicine, Tohoku University Hospital, Sendai, Japan.
  • International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.

ORCID-Profile: Aoi Noda, Masatsugu Orui

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Noda, A., Arita, R., Obara, T., Suzuki, S., Ohsawa, M., Obara, R., Morishita, K., Ueno, F., Matsuzaki, F., Shinoda, G., Murakami, K., Orui, M., Ishikuro, M., Kikuchi, A., Takayama, S., Ishii, T., & Kuriyama, S. (2024). The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70033

Vancouver

Noda A, Arita R, Obara T, Suzuki S, Ohsawa M, Obara R, et al. The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70033

BibTeX
@article{Noda2024,
  author = {Noda, Aoi and Arita, Ryutaro and Obara, Taku and Suzuki, Satoko and Ohsawa, Minoru and Obara, Ryo and Morishita, Kei and Ueno, Fumihiko and Matsuzaki, Fumiko and Shinoda, Genki and Murakami, Keiko and Orui, Masatsugu and Ishikuro, Mami and Kikuchi, Akiko and Takayama, Shin and Ishii, Tadashi and Kuriyama, Shinichi},
  title = {The Use of Japanese Traditional (Kampo) Medicines Before and During Pregnancy in Japan: The Tohoku Medical Megabank Project Birth and Three‐Generation Cohort Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  doi = {10.1002/pds.70033}
}
Kostenlos starten →